Technetium (99mTc)

DRUG4 trials

Sponsors

Universitair Medisch Centrum Utrecht, BTG International Inc., Isabelle Henskens, Vastra Gotaland Region

Conditions

Breast CancerFluorescence ImagingIndocyanine Green (ICG)Lymph Node MappingLymphatic MetastasisMelanoma (Skin Cancer)Oral cancerRadioisotopes

Phase 3

Sentinel lymph node (SLN) detection in early oral cancer using Gallium-68-Tilmanocept PET/CT.

SuspendedCTIS2025-521682-27-00

Universitair Medisch Centrum UtrechtOral cancer

Target: 94Updated: 2025-04-18

Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma, a Randomized Phase III Multi-center Non- Inferiority Trial: MagMen-II

Not yet recruitingNCT07552597

Vastra Gotaland RegionMelanoma (Skin Cancer)

Start: 2026-05-04End: 2029-12-31Target: 254Updated: 2026-04-27

Unknown Phase

A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.

CompletedNCT06024213

BTG International Inc.Breast Cancer

Start: 2023-06-06End: 2023-12-19Updated: 2024-05-10

Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

RecruitingNCT07146295

Isabelle HenskensBreast Cancer, Fluorescence Imaging, Indocyanine Green (ICG) +6

Start: 2025-04-18End: 2026-08-31Target: 1760Updated: 2026-01-12